Phospholipid Market Report 2026

The phospholipid market size has grown strongly in recent years. It will grow from $3.81 billion in 2025 to $4.1 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to growth of pharmaceutical manufacturing activities, expansion of nutraceutical product development, rising demand for functional food ingredients, increasing extraction from soy and egg sources, availability of refined lipid processing technologies.

The phospholipid market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing investments in advanced drug delivery technologies, rising demand for plant-based emulsifiers, expansion of personalized nutrition products, growing adoption of phospholipids in cosmetic formulations, increasing focus on high-bioavailability ingredients. Major trends in the forecast period include increasing use of phospholipids in drug delivery systems, rising demand for natural emulsifiers in food and nutrition, growing adoption in liposomal formulations, expansion of high-purity pharmaceutical grades, enhanced focus on functional lipid ingredients.

The rise in demand for green and organic food is expected to boost the growth of the phospholipid market going forward. Green and organic food refers to food produced without synthetic chemicals, using environmentally sustainable practices. The use of green and organic food in phospholipids emphasizes deriving natural, eco-friendly sources to create healthier and more sustainable phospholipid-based products. For instance, in December 2023, according to the United States Department of Agriculture, a US-based federal agency, India produced 2.9 million metric tons of certified edible organic products for 2022-23. Therefore, the growing preference for green and organic food is driving demand for phospholipids.

Product innovation has emerged as a key trend gaining traction in the phospholipid market. Leading companies in the sector are developing cutting-edge products to enhance their market presence. For example, in May 2024, Aker BioMarine, a biotechnology innovator based in Norway, introduced PL+ DHA/EPA delivery technology. This innovative platform leverages natural marine phospholipids to improve the absorption of other ingredients. It enables dual solubility in both water and fats, functioning as an emulsifier and increasing absorption by up to 25 times. The formulation combines krill phospholipids with processed fish oil to create more effective emulsions for the uptake of EPA and DHA in the stomach.

In July 2023, Croda International Plc acquired Solus Biotech for an undisclosed amount. This acquisition expands Croda's access to Solus’ biotech-derived ceramide and phospholipid technologies, along with emerging capabilities in natural retinol. Solus Biotech, based in South Korea, produces phospholipids at a GMP plant, offering applications as delivery systems for pharmaceutical actives and cosmetics.

Major companies operating in the phospholipid market are The Archer-Daniels-Midland Company, Bunge India Private Limited, Cargill Incorporated, Wilmar International Limited, Lasenor Emul SL, Kewpie Corporation, Lipoid GmbH, VAV Life Sciences Pvt. Ltd., Avanti Polar Lipids Inc., Lecico GmbH, Sime Darby Oils Zwijndrecht Refinery B.V., Stern-Wywiol Gruppe, Berg + Schmidt India Pvt. Ltd., Novastell India Private Limited, American Lecithin Company, Beijing Gingko-Group Biological Technology Co. Ltd., Bergstrom Nutrition Inc., BioActor BV, Bioiberica S.A.U., Croda International Plc., Enzymotec Ltd., Gnosis Advanced Biotech, Jiusan Oils & Grains Industries Group, Kerry Group plc.

North America was the largest region in the phospholipid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the phospholipid market during the forecast period. The regions covered in the phospholipid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phospholipid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phospholipid market consists of sales of phosphatidylinositol, cardiolipin, and sphingomyelin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.